Accretion Pharmaceuticals, a Gujarat-based pharma manufacturer, concluded its SME IPO with a strong subscription of 7.31 times. The IPO, priced at Rs 96-101 per share, aims to utilize proceeds for capital expenditures and facility upgrades. Despite robust financial growth and international presence, the grey market premium remained flat, indicating market caution ahead of its NSE SME platform listing.
US stocks: US market ends higher as Amazon soothes AI jitters
Wall Street closed higher on Friday, driven by Amazon’s strong quarterly report. The tech giant’s results eased concerns about AI infrastructure spending. Apple’s stock dropped